The word "amyloid" is a correct and usable word in written English.
It refers to a type of protein that can build up in certain organs and tissues, potentially causing health problems. You can use the word "amyloid" when talking about medical conditions or research related to the protein. For example: "The patient's brain scans showed signs of amyloid, indicating a possible diagnosis of Alzheimer's disease."
Of those, only one both blocks egg-laying and causes amyloid protein to build up in mammalian cells.
A faulty presenilin gene leads to a build-up of the "amyloid" protein characteristic of the condition.
Their working hypothesis is that the low-grade infection causes inflammation, which in turn causes the amyloid to start gumming up.
Dr Kelly has now shown that atheronals can, at least in a test tube, trigger the sort of misfolding in amyloid proteins which is believed to lead to the formation of plaques.
It might simply be that brains which are riddled with the "amyloid" protein plaques which characterise the disease are also more susceptible to infection.In this section Much ado about almost nothing Barking up the wrong tree?
For the past decade there has been a lot of work on drugs called secretase inhibitors, which alter the activity of the enzymes that create amyloid beta-peptide 42.Researchers have known for some time that the long-term use of aspirin and ibuprofen, which belong to a group of drugs called non-steroidal anti-inflammatories, roughly halves a person's risk of developing Alzheimer's.
He gave volunteers a supplement containing curcumin, a chemical that binds to beta-amyloid and acts as a fluorescent tag.
Dr Frost's scanner detected the tagged beta-amyloid in the volunteers' retinas.
New tests presented in Copenhagen provide further alternatives, searching for dementia in neither the brain nor the blood, but in the eye and the nose.Shaun Frost of the Commonwealth Scientific and Industrial Research Organisation, in Australia, focused his research on beta-amyloid in the retina.
Unfortunately, this has not deterred researchers keen on amyloid-beta.One of the leaders of the most recent failed trial said they still believe in the amyloid-beta hypothesis, which continues to be the status quo.
One of the telltale signs of this disease is the deposit of beta-amyloid plaques in the brain.
